Page last updated: 2024-08-22

vidarabine and Erythremia

vidarabine has been researched along with Erythremia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broers, AE; Janssen, JJ; Raymakers, R; Slot, S; Smits, K; Te Boekhorst, PA; van de Donk, NW; Witte, BI; Zweegman, S	1
HANDA, H; KARASAWA, M; MATSUSHIMA, T; MAWATARI, M; MURAKAMI, H; NOJIMA, Y; OSAKI, Y; SAITOH, T; SEKIGAMI, T; TAHARA, K; TOYAMA, K; TSUKAMOTO, N; UCHIUMI, H; YOKOHAMA, A	1

Other Studies

2 other study(ies) available for vidarabine and Erythremia

Article	Year
Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis. Bone marrow transplantation, 2015, Volume: 50, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Calreticulin; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Disease Progression; Female; Graft Survival; Humans; Janus Kinase 2; Male; Melphalan; Middle Aged; Myeloablative Agonists; Neutrophils; Peripheral Blood Stem Cell Transplantation; Polycythemia Vera; Primary Myelofibrosis; Receptors, Thrombopoietin; Retrospective Studies; Thrombocythemia, Essential; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult	2015
Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:11 Topics: Female; Graft vs Host Disease; Humans; Janus Kinase 2; Melphalan; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Stem Cell Transplantation; Transplantation Conditioning; Treatment Outcome; Vidarabine	2009

Article

Year

Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.

Bone marrow transplantation, 2015, Volume: 50, Issue:11

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Calreticulin; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Disease Progression; Female; Graft Survival; Humans; Janus Kinase 2; Male; Melphalan; Middle Aged; Myeloablative Agonists; Neutrophils; Peripheral Blood Stem Cell Transplantation; Polycythemia Vera; Primary Myelofibrosis; Receptors, Thrombopoietin; Retrospective Studies; Thrombocythemia, Essential; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult

2015

Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:11

Topics: Female; Graft vs Host Disease; Humans; Janus Kinase 2; Melphalan; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Stem Cell Transplantation; Transplantation Conditioning; Treatment Outcome; Vidarabine

2009